NCT05868902 - A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia. | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

August 28, 2023

Primary Completion Date

June 1, 2025

Study Completion Date

December 31, 2025

Conditions

Coronary; Ischemic

Interventions

DEVICE

CardioFlux Magnetocardiography

The device is a magnetocardiography (MCG) scanner named CardioFlux, which is paired with a cloud processing software. CardioFlux devices are owned by Genetesis and are currently cleared for the acquisition, display, and analysis of magnetic fields generated by cardiac electrical activity (K182571, FDA clearance letter available for download online)

Trial Locations (2)

44195

RECRUITING

Cleveland Clinic, Cleveland

45429

RECRUITING

Kettering Health, Kettering